{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T20:25:06Z","timestamp":1790799906800,"version":"4.1.0"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1097\/mnm.0b013e32831089cb","type":"journal-article","created":{"date-parts":[[2008,10,30]],"date-time":"2008-10-30T07:10:03Z","timestamp":1225350603000},"page":"1046-1051","source":"Crossref","is-referenced-by-count":47,"title":["18F-FDG PET\/CT evaluation of patients with ovarian carcinoma"],"prefix":"10.1097","volume":"29","author":[{"given":"Andrei H.","family":"Iagaru","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik S.","family":"Mittra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain Ross","family":"McDougall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Quon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv Sam","family":"Gambhir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-4-20210212","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3322\/CA.2007.0010","article-title":"Cancer statistics, 2008","volume":"58","author":"Jemal","year":"2008","journal-title":"CA Cancer J Clin"},{"key":"R2-4-20210212","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.rcl.2006.10.012","article-title":"Ovarian cancer","volume":"45","author":"Mironov","year":"2007","journal-title":"Radiol Clin North Am"},{"key":"R3-4-20210212","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1038\/nrc882","article-title":"Molecular imaging of cancer with positron emission tomography","volume":"2","author":"Gambhir","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"R4-4-20210212","first-page":"7445","article-title":"Prediction of response to neoadjuvant chemotherapy by sequential F-18-fluorodeoxyglucose positron emission tomography in patients with advanced-stage ovarian cancer","volume":"23","author":"Avril","year":"2005","journal-title":"Clin Oncol"},{"key":"R5-4-20210212","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S1095-0397(01)00053-X","article-title":"Clinical impact of 18F-FDG-PET in the suspicion of recurrent ovarian carcinoma based on elevated tumor marker serum levels","volume":"3","author":"Jim\u00e9nez-Bonilla","year":"2000","journal-title":"Clin Positron Imaging"},{"key":"R6-4-20210212","first-page":"329","article-title":"Usefulness of whole body positron emission tomography (PET) with 18F-fluoro-2-deoxyglucose (FDG) to detect recurrent ovarian cancer based on asymptomatically elevated serum levels of tumor marker","volume":"49","author":"Chang","year":"2002","journal-title":"Neoplasma"},{"key":"R7-4-20210212","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s00066-004-1208-3","article-title":"The influence of CA 125 and CEA levels on the results of (18)F-deoxyglucose positron emission tomography in suspected recurrence of epithelial ovarian cancer","volume":"180","author":"Menzel","year":"2004","journal-title":"Strahlenther Onkol"},{"key":"R8-4-20210212","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S1095-0397(00)00094-7","article-title":"Accuracy of qualitative and semiquantitative analysis of 18FDG positron emission tomography scans in the evaluation of primary and metastatic lesions","volume":"3","author":"Giorgetti","year":"2000","journal-title":"Clin Positron Imaging"},{"key":"R9-4-20210212","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1002\/(SICI)1097-0258(19981130)17:22<2635::AID-SIM954>3.0.CO;2-C","article-title":"Improved confidence intervals for the difference between binomial proportions based on paired data","volume":"17","author":"Newcombe","year":"1998","journal-title":"Stat Med"},{"key":"R10-4-20210212","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1007\/s00259-002-0878-2","article-title":"Usefulness of (18)F-FDG PET in the post-therapy surveillance of endometrial carcinoma","volume":"29","author":"Belhocine","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R11-4-20210212","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s00259-005-1876-y","article-title":"18F-FDG PET in the management of endometrial cancer","volume":"33","author":"Chao","year":"2006","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R12-4-20210212","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2214\/ajr.179.2.1790391","article-title":"Usefulness of FDG PET for assessment of early recurrent epithelial ovarian cancer","volume":"179","author":"Cho","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"R13-4-20210212","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1007\/s00259-007-0366-9","article-title":"Diagnostic accuracy of FDG PET in the follow-up of platinum-sensitive epithelial ovarian carcinoma","volume":"34","author":"Garc\u00eda-Velloso","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R14-4-20210212","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ygyno.2004.12.007","article-title":"FDG-PET for management of cervical and ovarian cancer","volume":"97","author":"Havrilesky","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R15-4-20210212","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/gyno.1993.1272","article-title":"Assessment of primary and metastatic ovarian cancer by positron emission tomography (PET) using 2-[18F]deoxyglucose (2-[18F]FDG)","volume":"51","author":"Hubner","year":"1993","journal-title":"Gynecol Oncol"},{"key":"R16-4-20210212","first-page":"2045","article-title":"Is 18F-FDG PET\/CT useful for imaging and management of patients with suspected occult recurrence of cancer?","volume":"45","author":"Israel","year":"2004","journal-title":"J Nucl Med"},{"key":"R17-4-20210212","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/BF03027393","article-title":"Diagnostic accuracy of FDG PET imaging for the detection of recurrent or metastatic gynecologic cancer","volume":"19","author":"Khan","year":"2005","journal-title":"Ann Nucl Med"},{"key":"R18-4-20210212","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s003300051000","article-title":"Value of (18F)-FDG positron emission tomography, computed tomography, and magnetic resonance imaging in diagnosing primary and recurrent ovarian carcinoma","volume":"10","author":"Kubik-Huch","year":"2000","journal-title":"Eur Radiol"},{"key":"R19-4-20210212","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1586\/14737140.6.7.1033","article-title":"Positron emission tomography in gynecological malignancies","volume":"6","author":"Kumar","year":"2006","journal-title":"Expert Rev Anticancer Ther"},{"key":"R20-4-20210212","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1006\/gyno.2002.6606","article-title":"Positron emission tomography\/computed tomography imaging for the detection of recurrent ovarian and fallopian tube carcinoma: a retrospective review","volume":"85","author":"Makhija","year":"2002","journal-title":"Gynecol Oncol"},{"key":"R21-4-20210212","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2214\/ajr.176.6.1761449","article-title":"Clinical value of positron emission tomography with FDG for recurrent ovarian cancer","volume":"176","author":"Nakamoto","year":"2001","journal-title":"AJR Am J Roentgenol"},{"key":"R22-4-20210212","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF02990022","article-title":"Clinical value of FDG-PET in the follow up of post-operative patients with endometrial cancer","volume":"17","author":"Saga","year":"2003","journal-title":"Ann Nucl Med"},{"key":"R23-4-20210212","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s10147-005-0489-6","article-title":"Positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer","volume":"10","author":"Takekuma","year":"2005","journal-title":"Int J Clin Oncol"},{"key":"R24-4-20210212","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1007\/s00259-001-0750-9","article-title":"Ovarian cancer recurrence: role of whole-body positron emission tomography using 2-[fluorine-18]-fluoro-2-deoxy-D-glucose","volume":"29","author":"Torizuka","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R25-4-20210212","first-page":"3691","article-title":"Whole body positron emission tomography with 18F-fluoro-2-deoxyglucose for the detection of recurrent ovarian cancer","volume":"21","author":"Yen","year":"2001","journal-title":"Anticancer Res"},{"key":"R26-4-20210212","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/00001703-200302000-00011","article-title":"Positron emission tomography scanning in gynecologic and breast cancers","volume":"15","author":"Zimny","year":"2003","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R27-4-20210212","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1200\/JCO.2004.08.120","article-title":"Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET\/CT) for tumor staging in solid tumors: comparison with CT and PET","volume":"22","author":"Antoch","year":"2004","journal-title":"J Clin Oncol"},{"key":"R28-4-20210212","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2214\/ajr.171.4.9763005","article-title":"Imaging of oncologic patients: benefit of combined CT and FDG PET in the diagnosis of malignancy","volume":"171","author":"Eubank","year":"1998","journal-title":"AJR Am J Roentgenol"},{"key":"R29-4-20210212","first-page":"77","article-title":"Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment","volume":"47","author":"Picchio","year":"2003","journal-title":"Q J Nucl Med"},{"key":"R30-4-20210212","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1148\/radiol.2332031800","article-title":"Integrated FDG PET\/CT in patients with persistent ovarian cancer: correlation with histologic findings","volume":"233","author":"Sironi","year":"2004","journal-title":"Radiology"},{"key":"R31-4-20210212","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1007\/s00259-006-0251-y","article-title":"Post-therapy surveillance of patients with uterine cancers: value of integrated FDG PET\/CT in the detection of recurrence","volume":"34","author":"Sironi","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"R32-4-20210212","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.ygyno.2006.11.022","article-title":"The diagnostic value of PET\/CT for primary ovarian cancer-A prospective study","volume":"105","author":"Risum","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R33-4-20210212","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ejso.2005.02.029","article-title":"18)F-FDG PET\/CT in the evaluation of recurrent ovarian cancer: a prospective study on forty-one patients","volume":"31","author":"Nanni","year":"2005","journal-title":"Eur J Surg Oncol"},{"key":"R34-4-20210212","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ygyno.2006.10.060","article-title":"Clinical use of combined positron emission tomography and computed tomography (FDG-PET\/CT) in recurrent ovarian cancer","volume":"105","author":"Thrall","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R35-4-20210212","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1007\/s00259-006-0306-0","article-title":"Integrated PET\/CT as a first-line re-staging modality in patients with suspected recurrence of ovarian cancer","volume":"34","author":"Mangili","year":"2007","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00006231-200812000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T06:45:46Z","timestamp":1618037146000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006231-200812000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":35,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e32831089cb","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}